|
SCIENTIFIC PROGRAM
Thursday,
November 18th, 2004
17:00-18:00 Registration - (School of
Medicine, 1st floor, Salon de Actos)
18:00-18:30 Opening Ceremony
18:00-19:00 Opening Lecture
Chairman: F. Casanueva (Spain), C. Dieguez (Spain), M. Pombo (Spain)
A century of growth hormone research revisited - from linear models to
network complexity
C. Kordon (France)
19.30 Welcome Cocktail - (Hotel Reyes Catolicos)
Friday,
November 19th, 2004
- SESSION I -
Basic Concepts On Ghrelin Regulation And Action
Chairman: J. P. Castano (Spain) and G.
Cuatrecasas (Spain)
09:00-09:30 Background and hypothalamic
regulation
S. L. Dickson (Sweden)
09:30-10:00 Endocrine and cardiovascular actions
E. Ghigo (Italy)
10:00-10:30 The neuroendocrinology of "diabesity": Perspectives
for drug hunting.
M. Tschoep (USA-Germany)
10:30-11:00 Regulation of gonadal function
M. Tena-Sempere (Spain)
11:00-11:30 Coffee-break
- SESSION II -
Growth Hormone
Chairman: A. Spada (Italy) and B. Bonet (Spain)
11:30-12:00 Origin and fate of the GH cell
network
P. Mollard (France)
12:00-12:30 Regulation of the somatotrope axis
I. C. A. F. Robinson (UK)
12:30-13:00 The biological meaning of GH pulsatility
A. Barkan (USA)
13:00-13:30 Assessment by microarrays of GH biological action
G. Norstedt (Sweden)
13:30-15:30 Lunch - (Hotel Reyes Catolicos)
- SESSION III -
GH Deficiency
Chairman: A. Ferrandez (Spain) and M.
Mascarenhas (Spain)
15:30-16:00 Genetic basis of short stature
L. Castro (Spain)
16:00-16:30 Intrauterine growth retardation
A. C. S. Hokken-Koelega (Holland)
16:30-17:00 Radiation-induced hypopituitarism"
S. Shalet (UK)
17:00-17:30 Metabolic consequences of GH deficiency
J.O. Jørgensen (Denmark)
17:30-18:30 POSTER SESSION & coffee-break
Saturday,
November 20th, 2004
- SESSION IV -
GH Excess
Chairman: S. Webb (Spain) and TBC
09:00-09:30 Diagnostic and therapeutic consensus of acromegaly
A. Giustina (Italy)
09:30-10:00 The outcome of surgery and radiotherapy, the endocrinologist
view
D. Kleinberg (USA)
10:00-10:30 Severe systemic complications of acromegaly
A. Colao (Italy)
10:30-11:00 The critical parameters in GH excess
M. Sheppard (UK)
11:00-11:30 Coffee-break
- SESSION V -
The role of IGF
Chairman: J. P. Lopez- Siguero (Spain) and
P. Martul (Spain)
11:30-12:00 Biological actions of liver-derived
IGF-I
D. Le Roith (USA)
12:00-12:30 The IGF-1 system in children
J. Argente (Spain)
12:30-13:00 The debated relationship IGF-I - cancer
J. Wass (UK)
13:00-13:30 The genetic control of IGF-I levels and its consequences
S. W. J. Lamberts (The Netherlands)
13:30-15:30 Lunch¡ - (Hotel Reyes Catolicos)
- SESSION VI -
New Agents And New Indications
Chairman: A. Leal (Spain) and R. Blizzard
(USA)
15:30-16:00 Hypopituitarism as a
consequence of traumatic brain injury - call for attention
V. Popovic (Serbia-Montenegro)
16:00-16:30 Indications for GH replacement in adolescents and young adults
J. P. Monson (UK)
16:30-17:00 Deficiency of the IGF system associated with inactivation of
the ASL gene
H. M. Domené (Argentina)
17:00-17:30 From cell biology to clinic. New therapeutic strategies
P. H. Jacquet (France)
17:30- 17:45 Closing Remarks
R. Blizzard (USA)
|